Regulation (EC) No 726/2004 Article 80

Article 80

To ensure an appropriate level of transparency, the Management Board, on the basis of a proposal by the Executive Director and in agreement with the Commission, shall adopt rules to ensure the availability to the public of regulatory, scientific or technical information concerning the authorisation or supervision of medicinal products which is not of a confidential nature. The internal rules and procedures of the Agency, its committees and its working groups shall be made available to the public at the Agency and on the Internet. TITLE V GENERAL AND FINAL PROVISIONS

Read the full instrument → · Read this in context: TITLE IV — THE EUROPEAN MEDICINES AGENCY - RESPONSIBILITIES AND ADMINISTRATIVE STRUCTURE →

Other provisions in TITLE IV — THE EUROPEAN MEDICINES AGENCY - RESPONSIBILITIES AND ADMINISTRATIVE STRUCTURE

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationArticle 80 of Regulation (EC) No 726/2004 (LawPlayer, data as of 2026-07-04)

What to look at next

Regulation (EC) No 726/2004, full textChapter navigation and full text, so you can read this section in contextEuropean Union legislation EU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and year TITLE IV — THE EUROPEAN MEDICINES AGENCY - RESPONSIBILITIES AND ADMINISTRATIVE STRUCTURE — read this in contextThe surrounding text of the act in order, so you can see what comes before and afterChapters and sections